Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/38658
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEckenstaler, Robert-
dc.contributor.authorBenndorf, Ralf-
dc.date.accessioned2021-10-06T12:20:21Z-
dc.date.available2021-10-06T12:20:21Z-
dc.date.issued2020-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/38904-
dc.identifier.urihttp://dx.doi.org/10.25673/38658-
dc.description.abstractABCG2 belongs to the ABC transporter superfamily and functions as a poly-specific efflux pump. As it can transport a broad spectrum of substrates out of cells, ABCG2 is thought to alter the pharmacokinetics of drugs applied to treat certain diseases. Especially, its potential to induce resistance to chemotherapy is currently the object of intense research. To foster understanding of mechanisms relevant for substrate recognition and selection of ABCG2 substrates and to finally develop selective therapeutic modulators (e.g. inhibitors) of ABCG2 transport activity, it is important to further explore the precise 3D structure of the transporter. While efforts to elucidate the three-dimensional structure of ABCG2 using X-ray crystal structure analysis have not been successful so far, high-resolution cryo-electron microscopy-based investigations have revealed exciting new insights into the structure and function of the transporter. In this review, we will focus on these seminal publications to summarize the current understanding of tertiary and quaternary structure, homodimerization or oligomerization, and functions of the ABCG2 transporter protein.eng
dc.description.sponsorshipPublikationsfond MLU-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subject.ddc615-
dc.title3D structure of the transporter ABCG2 : what's new?eng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleBritish journal of pharmacology-
local.bibliographicCitation.volume177-
local.bibliographicCitation.issue7-
local.bibliographicCitation.pagestart1485-
local.bibliographicCitation.pageend1496-
local.bibliographicCitation.publishernameWiley-
local.bibliographicCitation.publisherplaceMalden, MA-
local.bibliographicCitation.doi10.1111/bph.14991-
local.openaccesstrue-
dc.identifier.ppn176495680X-
local.bibliographicCitation.year2020-
cbs.sru.importDate2021-10-06T12:19:15Z-
local.bibliographicCitationEnthalten in British journal of pharmacology - Malden, MA : Wiley, 1946-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
bph.14991.pdf3.36 MBAdobe PDFThumbnail
View/Open